Drugs

, Volume 57, Issue 2, pp 214–214 | Cite as

Basiliximab

A Viewpoint by Giuseppe Remuzzi
  • Giuseppe Remuzzi
Adis New Drug Profile Guest Commentary
  • 15 Downloads

Keywords

Mycophenolate Mofetil Basiliximab Favourable Safety Profile Acute Rejection Episode Kidney Recipient 

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Giuseppe Remuzzi
    • 1
  1. 1.Mario Negri Institute for Pharmacological ResearchBergamoItaly

Personalised recommendations